Bibliography
- The Cytokine Handbook. 2nd Ed., Academic Press USA (1994) 145–168.
- WENDLING D, RACADOT E, WIJDENES J: Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J. Rheumatol. (1993) 20:259–262.
- JILKA RL, HANGOC G, GIRASOLE G et al.: Increased os-teoclast development after estrogen loss: mediation by interleukin-6. Science (1992) 257:88–91.
- TANAKA K, AIKAWA Y, KAWASAKI H et al.: Pharmacological studies on 3-formy1-7-methyl-sulfonylamino-6-phenoxy-411-1-benzopyran-4-one (T-614), a novel anti-inflammatory agent. 4th communication: inhibitory effect on the production of interleukin-1 and interleukin-6. J. Pharmacobiodyn. (1992) 15:649–655.
- BUXTON IL, CHEEK DJ, ECKMAN DP et al: NG-nitro t-a-rginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res. (1993) 72:387–395.
- MOORE WM, WEBBER WM, JEROME GM et al.: t-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J. Med. Chem. (1994) 37:3886–3888.
- FREY C, NARYANAN K, MC MILLAN K et al.: t-thiocitru-Hine. A stereospecific, heme-binding inhibitor of nitric-oxide synthases. J. Biol. Chem. (1994) 269:26083–26091. .11,11
- GARVEY EP, OPLINGER JA, TANOURY PA et al.: Potent and selective inhibition of human nitric oxide syn-thases. Inhibition by non-amino acid isothioureas. J. Biol. Chem. (1994) 269:26669–26676.
- NAKANE M, KLINGHOFER V et al.: Novel potent and se-lective inhibitors of inducible nitric oxide synthase. Mole. Pharm. (1995) 47:831–834.
- WEBBER RK, METZ S, MOORE WM et al.: Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms. J. Med. Chem. (1998) 41:96–101.
- •Describes potent and selective iNOS inhibitors.
- TILTON RG, CHANG K, HASSAN KS et al.: Prevention of diabetic vascular dysfunction by guanidines. Inhibi-tion of nitric oxide synthase versus advanced glyca-tion end-product formation. Diabetes (1993) 42:221–232.
- SCHINI VB, VANHOUTTE PM: Inhibitors of calmodulin impair the constitutive but not the inducible nitric ox-ide synthase activity in the rat aorta. J. Pharm. Exp. Ther. (1992) 261:553–559.
- PALACIOS M, PADRON L, GLARIA L et al.: Chlorpromaz-ine inhibits both the constitutive nitric oxide synthase and the induction of nitric oxide synthase after LPS challenge. Biochem. Biophys. Res. Comms. (1993) 196:280.
- BUCK M, CHOJKIER M: Muscle wasting and dedifferen-tiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J. (1996) 15:1753–1765.
- BJORK L, TRACEY KJ, ULRICH P et al.: Targeted suppres-sionn of cytokine production in monocytes but not in T lymphocytes by a tetravalent guanlhydrazone. J. In-fect. Dis. (1997) 176:1303–1312.
- ••Discusses both IL-6 and NO inhibition.
- NEMETH ZH, HASKO G, SZABO C, VIZI ES: Amrinone and theophylline differentially regulate cytokine and nitric oxide production in endotoxemic mice. Shock (1997) 7:371–375.
- ••Discusses both IL-6 and NO inhibition.
- PAHAN K, SHEIKH FG, NAMBOODIRI AM, SINGH I Lo- and phenylacetate inhibit the induction of ni-tric oxide synthase and cytokines in primary, microglia and macrophages. J. Clin. Invest. (1997) 100:2671-2679. both IL-6 and NO inhibition.
- MATSUMURA K, SARAIE T et al.: Studies of nitriles. VII. Synthesis and properties of2-amino-3,3-dichloroacrylonitrile (ADAN). Chem. Pharm. (1976) 24:912–923.
- VINOGRADOVA TK, KISILENKO AA, DRACH BS: Synthe-sis of 2,4-substituted 5-mercaptooxazoles. Zh. Org. Khim. (1982) 18:1864–1869.
- •Starting material synthesis.
- MATSUMURA K, MIYASHITA O et al.: Studies of nitriles.. Synthesis and reactions of 2-acylamino-3,3-bis-(substitute d mercapto)acryloni-triles and their derivatives. A new synthesis of 2-substituted-5-(substituted mercapto)oxazole-4-carbonitriles and their derivatives. Chem. Pharm. (1976) 24:948–959.
- •Starting material synthesis.